Suppression of MCP-1, IFN-γ and IL-6 production of HNSCC ex vivo by pembrolizumab added to docetaxel and cisplatin (TP) exceeding those of TP alone is linked to improved survival - Wellhausen, Jana; Röhl, Louisa; Berszin, Michael; Krücken, Irene; Zebralla, Veit; Pirlich, Markus; Stoehr, Matthaeus; Wiegand, Susanne; Dietz, Andreas; Wald, Theresa; Wichmann, Gunnar (Frontiers in Immunology, 2025)